COPD: Page 7

Focus on comorbidities, socioeconomic factors could boost COPD care
A more holistic approach could help address health equity.
November 13, 2024
Indian doctor uses a stethoscope on an Indian woman.
Interstitial lung abnormality in COPD is inversely associated with comorbidity of lung cancer
A retrospective cohort examined more than 1,100 COPD patients.
November 6, 2024
Representative high-resolution CT images of COPD. (A) COPD without emphysema or ILA, (B) COPD with ILA but not emphysema, (C) COPD with emphysema but not ILA, (D) COPD with emphysema and ILA.
Childhood neglect associated with stroke, COPD and more
Researchers find link between childhood neglect and poor adult health outcomes with possible pathways for future treatment.
November 6, 2024
Black and white photo of a depressed child sitting on a worn sidewalk.
Sponsored
CDC respiratory virus guidance
Ascend Media
Review recommendations and updates to help prevent illness.
April 10, 2025
CDC respiratory virus guidance
Study reinforces Yupelri effectiveness in COPD treatment
The drug is the only FDA-approved, once-daily, nebulized long-acting muscarinic agonist.
October 30, 2024
Photo of a gloved hand putting drops of unknown liquid into test tubes with a masked medical person blurred in the background.
Phase 2 study set for COPD-related sarcopenia treatment
The study will evaluate the potential of RJx-01 to maintain muscle integrity in older people with severe COPD.
October 30, 2024
Elderly woman exercise walking in backyard with caregiver.
MMP-12 inhibitor shows promise in phase 1 trial
The novel and selective inhibitor could treat COPD, severe asthma and more.
October 24, 2024
Image of blocks spelling out phase 1 with the 1 being switched to 2.
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
FDA grants investigational clearance for new COPD, asthma drug
KT-621 is set to undergo a phase 1 clinical trial immediately.
October 24, 2024
microscope with lab glassware, science laboratory research and development concept
Biomarker can help assess the severity of COVID-19, COPD, asthma
Research is centered around IL-26, a signaling substance in the immune system.
October 17, 2024
charts showing the relationship between the plasma concentration of IL-26 and severity of COVID-19.
Lab-grown lung tissue could help treat respiratory illnesses
Advancements may help with organ transplantation as well.
October 11, 2024
Frontier Bio’s lab-grown lung tissue (left) produced using bioprinting combined with tissue self-assembly (~1 cm long). Under a microscope, the complex alveolar air sac microstructures can be seen (center and right).
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
FDA approves Dupixent for certain adults with COPD
The drug is the first biologic medicine approved for COPD in the U.S.
October 3, 2024
Glove hand Concept of FDA approved. Food and drugs administration.
AI could help predict ICU admissions for COPD patients
Earlier identification could facilitate timely escalation of care.
October 3, 2024
Image of hospital sign pointing toward the ICU.
COPD costs projected to skyrocket by 2029
Researchers predict amount spent on COPD could double what it was in 2019.
September 27, 2024
State variation in per-patient, COPD-attributable medical expenditures in 2019. Values are given in U.S. dollars.
Previous Page
Page 7 of 17
Next Page
Most Popular
GINA releases 2025 asthma guidelines update
Brinsupri becomes first FDA-approved therapy for NCFB
Alternative inflammatory pathways drive residual asthma exacerbations in children treated with mepolizumab
CHEST publishes new guideline on NSCLC management
Zinc’s emerging role in pediatric asthma, allergic rhinitis
Computerized decision support benefits children on ventilators for lung failure